| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on June 19, 2006
Accepted on November 1, 2006
Departments of Paediatric Endocrinology, Radiology, Urology, Pathology, Chemical Endocrinologyand Endocrinology, Radboud University Nijmegen Medical Centre, The Netherlands (*Present address: Department of Urology, VU University Medical Centre Amsterdam, The Netherlands)
* To whom correspondence should be addressed. E-mail: H.Claahsen{at}cukz.umcn.nl.
Context: In male patients with congenital adrenal hyperplasia (CAH) testicular adrenal rest tumors (TART) are frequently present. These tumors can interfere with testicular function. Intensifying glucocorticoid therapy does not always lead to tumor regression and improvement of testicular function. Recently testis-sparing surgery was introduced for treatment of TART.
Objective: Evaluation of tumor volume, symptoms and pituitary-gonadal function in male patients with CAH due to 21-hydroxylase deficiency and bilateral TART before and after testis-sparing surgery.
Setting: Radboud University Nijmegen Medical Centre, The Netherlands
Patients: 8 adult male CAH patients with bilateral TART and infertility.
Interventions: Evaluation of testicular MRI, symptoms, fasting serum concentrations of ACTH, LH, FSH, inhibin B, 17-OH progesterone, androstenedione, testosterone and oestron, and semen analysis (6 of 8 patients) before, and 6 and 22 months after testis-sparing surgery.
Main outcome measures: Absence of residual tumor. Improvement of symptoms and pituitary-gonadal function.
Results: In none of the patients residual tumor was found on MRI after surgery. Two patients reported testicular pain and discomfort that disappeared after surgery. Parameters of pituitary-gonadal function did not improve after surgery: Semen analysis showed azoospermia (5 patients) or oligospermia (1 patient) without improvement and all patients had persistently low inhibin B concentrations.
Conclusion: Testis-sparing surgery did not improve pituitary-gonadal function despite successful removal of the tumors. Further studies are needed to investigate whether surgery at an earlier stage in the natural history of TART can prevent permanent testicular damage.
This article has been cited by other articles:
![]() |
A. Martinez-Aguayo, A. Rocha, N. Rojas, C. Garcia, R. Parra, M. Lagos, L. Valdivia, H. Poggi, A. Cattani, and the Chilean Collaborative Testicular Adrenal Rest Testicular Adrenal Rest Tumors and Leydig and Sertoli Cell Function in Boys with Classical Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4583 - 4589. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L Claahsen-van der Grinten, F. C G J Sweep, J. G Blickman, A. R M M Hermus, and B. J Otten Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Eur. J. Endocrinol., September 1, 2007; 157(3): 339 - 344. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. L. Claahsen-van der Grinten, B. J. Otten, F. C. G. J. Sweep, P. N. Span, H. A. Ross, E. J. H. Meuleman, and A. R. M. M. Hermus Testicular Tumors in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency Show Functional Features of Adrenocortical Tissue J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3674 - 3680. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |